Hohenstein Axel, Erber Ralf, Schilling Lothar, Weigel Ralf
Department of Neurosurgery and Division of Neurosurgical Research, University Hospital, Mannheim, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Germany.
J Neurotrauma. 2005 May;22(5):518-28. doi: 10.1089/neu.2005.22.518.
The aim of the study was to determine the source of vascular endothelial growth factor (VEGF) in hematoma fluid of patients suffering from chronic subdural hematoma (CSH) and to identify the level of gene expression of the pro-angiogenic factors angiopoietin 1 (ANG-1) and ANG-2 in hematoma membranes. Samples of venous blood, hematoma fluid, and outer membrane were obtained during surgery for CSH. The numbers of mononuclear cells were determined in hematoma fluid and in venous blood samples taken from 11 patients. The concentration of VEGF was measured by ELISA technique in hematoma fluid and in plasma. RT-PCR methodology was used to study the expression of different mRNA species in 11 patients. The mRNA species analyzed include VEGF and its receptors, VEGFR-1 and VEGFR-2, and ANG-1, ANG-2 and their receptor, Tie-2. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as housekeeping gene and was used for semiquantitative analysis. The VEGF concentration was several hundred fold higher in the hematoma fluid than in corresponding plasma samples. A significant correlation was found between the number of neutrophils and the VEGF content in the hematoma fluid. The expression levels of VEGF, mainly VEGF165 and VEGF121 mRNA were highest in cells obtained from the hematoma fluid. In membrane samples, mRNA encoding for VEGF and its receptors was only inconsistently detected while the mRNA species encoding for ANG-1, ANG-2, and Tie-2 were found throughout all samples. The mean ratio of ANG-1/ANG-2 mRNA expression was 0.48 as opposed to 1.9 in a normal human brain tissue sample. The results suggest that the hematoma cells are the primary source of VEGF. A marked increase in the expression of ANG-2 mRNA over ANG-1 mRNA demonstrates a pro-angiogenic pattern in the hematoma membranes. Persistent activation of the ANG/Tie-2 system in addition to high levels of VEGF may keep the vasculature in a destabilized condition and may account for the continuous formation of new and immature blood vessels resulting in massive plasma extravasation and repeated bleeding episodes. Thus, the present study provides new evidence in favor of pro-angiogenic mechanisms playing an important role in the pathophysiology of CSH.
本研究的目的是确定慢性硬膜下血肿(CSH)患者血肿液中血管内皮生长因子(VEGF)的来源,并确定血肿膜中促血管生成因子血管生成素1(ANG-1)和ANG-2的基因表达水平。在CSH手术期间获取静脉血、血肿液和外膜样本。测定了11例患者血肿液和静脉血样本中的单核细胞数量。采用ELISA技术测定血肿液和血浆中VEGF的浓度。运用RT-PCR方法研究了11例患者不同mRNA种类的表达情况。分析的mRNA种类包括VEGF及其受体VEGFR-1和VEGFR-2,以及ANG-1、ANG-2及其受体Tie-2。甘油醛-3-磷酸脱氢酶(GAPDH)作为管家基因,用于半定量分析。血肿液中VEGF浓度比相应血浆样本高数百倍。发现中性粒细胞数量与血肿液中VEGF含量之间存在显著相关性。VEGF的表达水平,主要是VEGF165和VEGF121 mRNA在血肿液来源的细胞中最高。在膜样本中,仅偶尔检测到编码VEGF及其受体的mRNA,而编码ANG-1、ANG-2和Tie-2的mRNA在所有样本中均有发现。ANG-1/ANG-2 mRNA表达的平均比值为0.48,而在正常人类脑组织样本中为1.9。结果表明血肿细胞是VEGF的主要来源。ANG-2 mRNA表达相对于ANG-1 mRNA显著增加,表明血肿膜中存在促血管生成模式。除了高水平的VEGF外,ANG/Tie-2系统的持续激活可能使脉管系统处于不稳定状态,并可能解释新的和不成熟血管的持续形成,导致大量血浆外渗和反复出血事件。因此,本研究提供了新的证据,支持促血管生成机制在CSH病理生理学中起重要作用。